Oral Oncology Reports最新文献

筛选
英文 中文
Rare case of glandular odontogenic cyst in the posterior mandibular ramus: A case report 下颌后隆突腺源性牙源性囊肿的罕见病例:病例报告
Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100586
{"title":"Rare case of glandular odontogenic cyst in the posterior mandibular ramus: A case report","authors":"","doi":"10.1016/j.oor.2024.100586","DOIUrl":"10.1016/j.oor.2024.100586","url":null,"abstract":"<div><p>The glandular odontogenic cyst is a rare developmental cyst with odontogenic origins that shares similarities with other odontogenic lesions. While generally considered benign, GOCs can exhibit aggressive behavior and may transform into more aggressive lesions like ameloblastoma or mucoepidermoid carcinoma. Therefore, it is crucial to closely monitor and follow up after treatment. With less than 200 reported cases in the literature, GOCs are important due to their propensity for recurrence and potential confusion with other lesions. Oral and maxillofacial radiologists play a key role in diagnosing GOC, given its complex histopathology. In this particular case, a 14-year-old male presented with a well-defined radiolucent lesion in his posterior mandibular ramus, making it the third reported case of GOC in Syria. The discovery of the lesion was incidental, as it was found during a routine panoramic view. The radiolucent lesion extended from the distal border and apex of the lower right first premolar into the ramus, indicating the need for thorough diagnostic evaluation and proper management of the condition. This case report emphasizes the importance of recognizing and addressing such lesions early on to prevent any potential complications. As GOCs can be locally aggressive and have a tendency to recur, timely diagnosis and appropriate treatment are crucial in ensuring the best possible outcome for the patient. Further studies and research are needed to better understand the characteristics and behavior of GOCs in the mandibular ramus region.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004321/pdfft?md5=b4ee69158513ddae47d08f44daa9e24c&pid=1-s2.0-S2772906024004321-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141715687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Salivary exosomes as potential biomarkers in cancer” 关于 "作为癌症潜在生物标记物的唾液外泌体 "的评论
Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100577
Muthupandian Saravanan
{"title":"Comment on “Salivary exosomes as potential biomarkers in cancer”","authors":"Muthupandian Saravanan","doi":"10.1016/j.oor.2024.100577","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100577","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004230/pdfft?md5=f317c69d52343e34c64adf002c63bc30&pid=1-s2.0-S2772906024004230-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141593972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to editor: Comment on “multi-omics approach reveals promising salivary protein markers for head and neck squamous cell carcinoma prognosis" 致编辑的信关于 "多组学方法揭示了头颈部鳞状细胞癌预后的唾液蛋白标记 "的评论
Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100595
Gokul Sudhakaran
{"title":"Letter to editor: Comment on “multi-omics approach reveals promising salivary protein markers for head and neck squamous cell carcinoma prognosis\"","authors":"Gokul Sudhakaran","doi":"10.1016/j.oor.2024.100595","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100595","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004412/pdfft?md5=740753f7f79641d42b1cd07fe83cac30&pid=1-s2.0-S2772906024004412-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141593172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor, “Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – Implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy.” 致编辑的信,"头颈部鳞状细胞癌(HNSCC)的深度依赖性PD-L1取样--对PD-1/PD-L1检查点抑制剂免疫疗法的影响"。
Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100579
Geetha Shanmugam
{"title":"Letter to the editor, “Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – Implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy.”","authors":"Geetha Shanmugam","doi":"10.1016/j.oor.2024.100579","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100579","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004254/pdfft?md5=a6db3a8194989c6ae5594aa9d9874f58&pid=1-s2.0-S2772906024004254-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141594006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking the potential of antimicrobial peptides: Beta-defensins and the future of cancer diagnostics 发掘抗菌肽的潜力:β-防御素与癌症诊断的未来
Oral Oncology Reports Pub Date : 2024-07-03 DOI: 10.1016/j.oor.2024.100584
{"title":"Unlocking the potential of antimicrobial peptides: Beta-defensins and the future of cancer diagnostics","authors":"","doi":"10.1016/j.oor.2024.100584","DOIUrl":"10.1016/j.oor.2024.100584","url":null,"abstract":"<div><p>Oral cancer is a significant public health concern globally, with India reporting a high incidence rate. Genetic factors related to immunity, taste perception, and tooth mineralization are being increasingly studied in the context of dental caries. Beta-defensins, a group of antimicrobial peptides crucial for innate immunity, have been linked to oral cancer development. Studies have shown dysregulation of beta-defensins, particularly hBD-3, may contribute to oral squamous cell carcinoma progression via modulation of inflammation and immune responses. The Beta-defensin index (BDI), which measures hBD-3 and hBD-2 ratios, shows promise as a non-invasive test for early oral cancer detection. Clinical applications include guiding biopsy decisions and prognostication. Further research on beta defensins’ mechanisms and broader oncological implications is crucial for innovative therapeutic strategies.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004308/pdfft?md5=9c7ae401eef14b4cda4526a315639de5&pid=1-s2.0-S2772906024004308-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141630141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor, “Prevalence of oral side effects associated with chemo and radiotherapy in head and neck cancer treatment: A cross-sectional study in Egypt” 致编辑的信,"头颈部癌症化疗和放疗相关口腔副作用的发生率:埃及横断面研究"
Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100578
Gnanaprakash Jeyaraj
{"title":"Letter to the editor, “Prevalence of oral side effects associated with chemo and radiotherapy in head and neck cancer treatment: A cross-sectional study in Egypt”","authors":"Gnanaprakash Jeyaraj","doi":"10.1016/j.oor.2024.100578","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100578","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004242/pdfft?md5=317cde6dc9a51b29d5fae77abad25c74&pid=1-s2.0-S2772906024004242-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
End of life and palliative care decisions in advanced head neck cancer 晚期头颈部癌症患者的生命终结和姑息治疗决策
Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100569
Shrikant B. Mali
{"title":"End of life and palliative care decisions in advanced head neck cancer","authors":"Shrikant B. Mali","doi":"10.1016/j.oor.2024.100569","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100569","url":null,"abstract":"<div><p>The complexity of care for patients with advanced head and neck cancer is a significant issue, and current healthcare systems must focus on appropriate referral criteria, increased integration and coordination of care, and robust evaluation of specific care components. Linkage between research and service design delivery across teams, disciplines, and care settings is also important. Palliative care needs of patients with advanced head and neck cancer pose unique complexities due to the impact the illness has on eating, speaking, appearance, and breathing. Specialty palliative care consultation by trained experts helps primary teams facilitate goals of care discussions, symptom management, and medical resource navigation for the terminally ill patient. Early initiation of palliative care results in less invasive and more cost-effective patient-centered care. There is little literature on care practices in this population, and hospital-based care may increase towards the end of life to address potentially reversible conditions or uncertain prognosis. Early advanced care planning and end-of-life care options should be supported alongside continuation of therapy lines.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004151/pdfft?md5=a10e435122de333102e63e386f9366c9&pid=1-s2.0-S2772906024004151-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on “Unlocking the therapeutic potential of microalgal astaxanthin a super antioxidant in oral cancer and associated ailments” 关于 "挖掘微藻虾青素这种超级抗氧化剂对口腔癌及相关疾病的治疗潜力 "的评论
Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100571
Antonyraj Matharasi Perianaika Anahas, Ganapathy Dhanraj
{"title":"Comment on “Unlocking the therapeutic potential of microalgal astaxanthin a super antioxidant in oral cancer and associated ailments”","authors":"Antonyraj Matharasi Perianaika Anahas,&nbsp;Ganapathy Dhanraj","doi":"10.1016/j.oor.2024.100571","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100571","url":null,"abstract":"<div><p>Oral cancer treatment potentially advances with the application of C-phycocyanin (C-PC), a powerful antioxidant produced by cyanobacteria. By triggering mechanisms that impair the metabolism of mitochondria and cause cancer cells to initiate apoptosis, this pigment demonstrates potent apoptotic-inducing potentials. Innovative application for C-PC includes integrating it with fibrous scaffolds for long-term release, stimulating tissue regeneration, and lowering inflammation and oxidative damage after surgery. Surgical implants with C-PC, such stents and sutures, provide focused therapy at the locations of oral cancer. In order to enhance the therapeutic uses of C-PC in oral cancer, further studies may investigate genetically modified microalgae. Validating these therapeutic effects and advancing cyanobacterial pigment-based drugs into clinical applications demand further studies.</p></div>","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004175/pdfft?md5=b86cc38af07f9988a9c4308f83abc51e&pid=1-s2.0-S2772906024004175-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent? 二甲双胍的再利用:作为一种新辅助治疗药物,它能否彻底改变口腔癌治疗?
Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100575
Deepavalli Arumuganainar, Saravanan Sekaran
{"title":"Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent?","authors":"Deepavalli Arumuganainar,&nbsp;Saravanan Sekaran","doi":"10.1016/j.oor.2024.100575","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100575","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772906024004217/pdfft?md5=6585c1ff3dfb83918bf3eeec1e8dfc5d&pid=1-s2.0-S2772906024004217-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on, “How reliable is the assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? A multi-institutional study on 366 patients from the ARYFIX collaborative group” 评论:"评估喉癌患者声带-声门单元真实活动度的可靠性如何?ARYFIX合作小组对366名患者进行的一项多机构研究"
Oral Oncology Reports Pub Date : 2024-07-02 DOI: 10.1016/j.oor.2024.100568
Gokul Sudhakaran
{"title":"Comment on, “How reliable is the assessment of true vocal cord-arytenoid unit mobility in patients affected by laryngeal cancer? A multi-institutional study on 366 patients from the ARYFIX collaborative group”","authors":"Gokul Sudhakaran","doi":"10.1016/j.oor.2024.100568","DOIUrl":"https://doi.org/10.1016/j.oor.2024.100568","url":null,"abstract":"","PeriodicalId":94378,"journal":{"name":"Oral Oncology Reports","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277290602400414X/pdfft?md5=dedad0c793f344d053410f32dc3fd92a&pid=1-s2.0-S277290602400414X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141541468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信